Evasion of intracellular host defence by hepatitis C virus

Nature

Volumn 436, Issue 7053, 2005, Pages 939-945

  Gale Jr , Michael ^a   Foy, Eileen M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DRUG PRODUCTS; IMMUNIZATION; MOLECULES; SIGNALING;

ANTIVIRAL DRUGS; MAMMALIAN CELLS; TRIGGERS;

VIRUSES;

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON;

HEPATITIS;

ANTIVIRAL ACTIVITY; CYTOKINE PRODUCTION; EFFECTOR CELL; GENETIC VARIABILITY; HEPATITIS C; HEPATITIS C VIRUS; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; HEPACIVIRUS; HEPATITIS C; HOST-PARASITE RELATIONS; HUMANS; INTERFERONS; SIGNAL TRANSDUCTION;

HEPATITIS C VIRUS; MAMMALIA;

EID: 23944485662     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature04078     Document Type: Review

References (94)

1. Katze, M. G., He, Y. & Gale, M. Jr. Viruses and Interferon: a fight for supremacy. Nature Rev. Immunol. 2, 675-687 (2002).
2. Sen, G. C. Viruses and interferons. Annu. Rev. Microbiol. 55, 255-281 (2001).
3. Iwasaki, A. & Medzhitov, R. Toll-like receptor control of the adaptive immune responses. Nature Immunol. 5, 987-995 (2004).
4. Cook, D. N., Pisetsky, D. S. & Schwartz, D. A. Toll-like receptors in the pathogenesis of human disease. Nature Immunol. 5, 975-979 (2004).
5. McCormick, C. J., Challinor, L., Macdonald, A., Rowlands, D. J. & Harris, M. Introduction of replication-competent hepatitis C virus transcripts using a tetracycline-regulable baculovirus delivery system. J. Gen. Virol. 85, 429-439 (2004).
6. Sumpter, R. et al. Regulating intracellular anti-viral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 79, 2689-2699 (2005).
7. Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nature Immunol. 5, 730-737 (2004).
8. Li, K., Chen, Z., Kato, N., Gale, M. Jr & Lemon, S. M. Distinct poly-I: C and virus-activated signaling pathways leading to interferon-β production in hepatocytes. J. Biol. Chem. 280, 16739-16747 (2005).
9. Malmgaard, L. Induction and regulation of IFNs during viral infections. J. Interferon Cytokine Res. 24, 439-454 (2004).
10. Au, W. C., Moore, P. A., Lowther, W., Juang, Y. T. & Pitha, P. M. Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc. Natl Acad. Sci. USA 92, 11657-11661 (1995).
11. Lin, R., Heylbroeck, C., Genin, P., Pitha, P. M. & Hiscott, J. Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription. Mol. Cell. Biol. 19, 959-966 (1999).
12. Richmond, A. NF-κB, chemokine gene transcription and tumour growth. Nature Rev. Immunol. 2, 664-674 (2002).
13. Barnes, B. J., Moore, P. A. & Pitha, P. M. Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J. Biol. Chem. 276, 23382-23390 (2001).
14. Kawai, T. et al. Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nature Immunol. 5, 1061-1068 (2004).
15. Tai, D. I. et al. Activation of nuclear factor κB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology 31, 656-664 (2000).
16. Der, S. D., Zhou, A., Williams, B. R. G. & Silverman, R. H. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays. Proc Natl Acad. Sci. USA 95, 15623-15628 (1998).
17. Wang, C. et al. Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. J. Virol. 77, 3898-3912 (2002).
18. Shimazaki, T, Honda, M., Kaneko, S. & Kobayashi, K. Inhibition of internal ribosomal entry site-directed translation of HCV by recombinant IFN-α correlates with a reduced La protein. Hepatology 35, 199-208 (2002).
19. Guo, J., Bichko, V. & Seeger, C. Effect of alpha interferon on the hepatitis C virus replication. J. Virol. 75, 8516-8523 (2001).
20. Prabhu, R. et al. Interferon α-2b inhibits negative-strand RNA and protein expression from full-length HCV1a infectious clone. Exp. Mol. Pathol. 76, 242-252 (2004).
21. Foy, E. et al. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-1 signaling. Proc. Natl Acad. Sci. USA 102, 2986-2991 (2005).
22. Smith, M. W. et al. Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers. Hepatology 38, 1458-1467 (2003).
23. Honda, K. et al. IRF-7 is the master regulator of type-1 interferon-dependent immune responses. Nature 435, 772-777 (2005).
24. McHutchison, J. G. & Patel, K. Future therapy of hepatitis C. Hepatology 36, S245-S252 (2002).
25. Walker, C. M. Comparative features of hepatitis C virus infection in humans and chimpanzees. Springer Semin. Immunopathol. 19, 85-98 (1997).
26. Bigger, C. B., Brasky, K. M. & Lanford, R. E. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J. Virol. 75, 7059-7066 (2001).
27. Su, A. I. et al. Genomic analysis of the host response to hepatitis C virus infection. Proc. Natl Acad. Sci. USA 99, 15669-15674 (2002).
28. Bigger, C. et al. Intrahepatic gene expression during chronic hepatits C virus infection in chimpanzees J. Virol. 78, 13779-13792 (2004).
29. Tuplin, A., Wood, J., Evans, D. J., Patel, A. H. & Simmonds, P. Thermodynamic and phylogenetic prediction of RNA secondary structures in the coding region of hepatitis C virus. RNA 8, 824-841 (2002).
30. Fredericksen, B. et al. Activation of the inteferon-β promoter during hepatitis C virus RNA replication. Viral Immunol. 15, 29-40 (2001).
31. Blight, K. J., McKeating, J. A. & Rice, C. M. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76, 13001-13014 (2002).
32. Andrejeva, J. et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-β promoter. Proc. Natl Acad. Sci. USA 101, 17264-17269 (2004).
33. Yamamoto, M. et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301, 640-643 (2003).
34. Gong, G., Waris, G., Tanveer, R. & Siddiqui, A. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB. Proc. Natl Acad. Sci. USA 98, 9599-9604 (2001).
35. Sarcar, B., Ghosh, A. K., Steele, R., Ray, R. & Ray, R. B. Hepatitis C virus NS5A mediated STAT3 activation requires co-operation of Jak1 kinase. Virology 322, 51-60 (2004).
36. Zhu, H. et al. Gene expression associated with interferon a antiviral activity in an HCV replicon cell line. Hepatology 37, 1180-1188 (2003).
37. Delhem, N. et al. Activation of the interferon-inducible protein kinase PKR by hepatocellular carcinoma derived-hepatitis C virus core protein. Oncogene 20, 5836-5845 (2001).
38. Williams, B. R. PKR; a sentinel kinase for cellular stress. Oncogene 18, 6112-6120 (1999).
39. Tanaka, Y. et al. Selective binding of hepatitis C virus core protein to synthetic oligonucleotides corresponding to the 5′ untranslated region of the viral genome. Virology 270, 229-236 (2000).
40. Barth, H. et al. Uptake and presentation of hepatitis C virus-like particles by human dendritic cells. Blood 105, 3605-3614 (2005).
41. Colonna, M., Trinchieri, G. & Liu, Y. J. Plasmacytoid dendritic cells in immunity. Nature Immunol. 5, 1219-1226 (2004).
42. Li, K. et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl Acad. Sci. USA 102, 2992-2997 (2005).
43. Ferreon, J. C., Ferreon, A. C., Li, K. & Lemon, S. M. Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease. J. Biol. Chem. 280, 20483-20492 (2005).
44. Reed, K. E. & Rice, C. M. in Hepatitis C Virus (ed. Reesink, H. W.) 1-37 (Karger, Basel, 1998).
45. De Francesco, R. & Steinkuhler, C. Structure and function of the hepatitis C virus NS3-NS4A serine proteinase. Curr. Top. Microbiol. Immunol. 242, 149-169 (2000).
46. Foy, E. et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300, 1145-1148 (2003).
47. Sharma, S. et al. Triggering the interferon antiviral response through a novel IKK-related pathway. Science 300, 1148-1151 (2003).
48. Fitzgerald, K. A. et al. IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nature Immunol. 4, 491-496 (2003).
49. Shoukry, N. H., Cawthon, A. G. & Walker, C. M. Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu. Rev. Microbiol. 58, 391-424 (2004).
50. Duguay, D. et al. In vivo interferon regulatory factor 3 tumor suppressor activity in B16 melanoma tumors. Cancer Res. 62, 5148-5152 (2002).
51. Heylbroeck, C. et al. The IRF-3 transcription factor mediates Sendai virus-induced apoptosis. J. Virol. 74, 3781-3792 (2000).
52. Liang, T. J. & Heller, T. Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gostroenterology 127, S62-S71 (2004).
53. Zhu, H. & Liu, C. Interleukin-1 inhibits hepatitis C virus subgenomic RNA replication by activation of extracellular regulated kinase pathway. J. Virol. 77, 5493-5498 (2003).
54. Heim, M. H., Moradpour, D. & Blum, H. E. Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J. Virol. 73, 8469-8475 (1999).
55. Blindenbacher, A. et al. Expression of hepatitis C virus proteins inhibits interferon α signaling in the liver of transgenic mice. Gastroenterology 124, 1465-1475 (2003).
56. Duong, F. H., Filipowicz, M., Tripodi, M., La Monica, N. & Heim, M. H. Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A. Gastroenterology 126, 263-277 (2004).
57. Bode, J. G. et al. IFN-α antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J. 17, 488-490 (2003).
58. Alexander, W. S. Suppressors of cytokine signalling (SOCS) in the immune system. Nature Rev. Immunol. 2, 410-416 (2002).
59. Platanias, L. C. & Fish, E. N. Signaling pathways activated by interferons. Exp. Hematol. 27, 1583-1592 (1999).
60. Macdonald, A. & Harris, M. Hepatitis C virus NS5A: tales of a promiscuous protein. J. Gen. Virol. 85, 2485-2502 (2004).
61. Geiss, G. K. et al. Gene expression profiling of the cellular transcriptional network regulated by α/β interferon and its partial attenuation by the hepatitis C virus nonstructural 5A protein. J. Virol. 77, 6367-6375 (2003).
62. Khabar, K. S. et al. The alpha chemokine, interleukin 8, inhibits the antiviral action of interferon α. J. Exp. Med. 186, 1077-1085 (1997).
63. Polyak, S. J. et al. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J. Virol. 75, 6095-6106 (2001).
64. Polyak, S. J., Khabar, K. S., Rezeiq, M. & Gretch, D. R. Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy. J. Virol. 75, 6209-6211 (2001).
65. Taylor, D. R., Shi, S. T., Romano, P. R., Barber, G. N. & Lai, M. M. C. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285, 107-110 (1999).
66. Noguchi, T. et al. Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells. Microbiol. Immunol. 45, 829-840 (2001).
67. Gale, M. Jr et al. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol. Cell. Biol. 18, 5208-5218 (1998).
68. Gimenez-Barcons, M. et al. The oncogenic potential of hepatitis C virus NS5A sequence variants is associated with PKR regulation. J. Interferon Cytokine Res. 25, 152-164 (2005).
69. Sumpter, R., Wang, C., Foy, E., Loo, Y.-M. & Gale, M. J. Viral evolution and interferon resistance of hepatitis C virus RNA replication in a cell culture model. J. Virol. 78, 11591-11604 (2004).
70. Taguchi, T. et al. Hepatitis C virus NS5A protein interacts with 2́,5́-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner. J. Gen. Virol. 85, 959-969 (2004).
71. Han, J. Q. & Barton, D. J. Activation and evasion of the antiviral 2′,5′ oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA. RNA 8, 512-525 (2002).
72. Han, J. Q., Wroblewski, G., Xu, Z., Silverman, R. H. & Barton, D. J. Sensitivity of hepatitis C virus RNA to the antiviral enzyme ribonuclease L is determined by a subset of efficient cleavage sites. J. Interferon Cytokine Res. 24, 664-676 (2004).
73. Farci, P. Hepatitis C virus. The importance of viral heterogeneity. Clin. Liver Dis. 5, 895-916 (2001).
74. Farci, P. et al. Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome. Proc. Natl Acad. Sci. USA 99, 3081-3086 (2002).
75. Farci, P. et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288, 339-344 (2000).
76. Enomoto, N. et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus Ib infection. N. Engl. J. Med. 334, 77-81 (1996).
77. Pascu, M. et al. Sustained virological response in hepatitis C virus type Ib infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences. Gut 53, 1345-1351 (2004).
78. Schinkel, J., Spoon, W. J. & Kroes, A. C. Meta-analysis of mutations in the NS5A gene and hepatitis C virus resistance to interferon therapy: uniting discordant conclusions. Antivir. Ther. 9, 275-286 (2004).
79. Blight, K. J., Kolykhalov, A. A. & Rice, C. M. Efficient inititation of HCV RNA replication in cell culture. Science 290, 1972-1974 (2000).
80. Appel, N., Pietschmann, T. & Bartenschlager, R. Mutational analysis of hepatitis C virus nonstructural protein 5A: potential role of differential phosphorylation in RNA replication and identification of a genetically flexible domain. J. Virol. 79, 3187-3194 (2005).
81. Mihm, S. et al. Interferon type I gene expression in chronic hepatitis C. Lab. Invest 84, 1148-1159 (2004).
82. Fujita, T., Reis, L. F., Watanabe, N., Kimura, Y. & Taniguchi, T. Induction of the transcription factor IRF-1 and interferon-β mRNAs by cytokines and activators of second-messenger pathways. Proc. Natl Acad. Sci. USA 86, 9936-9940 (1986).
83. Schulz, O. et al. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433, 887-892 (2005).
84. Frese, M. et al. Interferon-γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35, 694-703 (2002).
85. McHutchison, J. G. Understanding hepatitis C. Am. J. Manag. Care 10, S21-S29 (2004).
86. Zhong, J. et al. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. USA 102, 9294-9299 (2005).
87. Lidenbach, B. D. & Rice, C. M. Complete replication of hepatits C virus in cell culture. Science 309, 623-626 (2005).
88. Wakita, T. et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nature Med. 11, 791-796 (2005).
89. Pflugheber, J. et al. Regulation of PKR and IRF-1 during hepatitis C virus RNA replication. Proc. Natl Acad. Sci. USA 99, 4650-4655 (2002).
90. Kanazawa, N. et al. Regulation of hepatitis C virus replication by interferon regulatory factor J. Virol. 78, 9713-9720 (2004).
91. McWhirter, S. M. et al. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonicfibroblasts. Proc. Natl Acad. Sci. USA 101, 233-238 (2004).
92. Yoneyama, M. et al. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17, 1087-1095 (1998).
93. Au, W. C., Yeow, W. S. & Pitha, P. M. Analysis of functional domains of interferon regulatory factor 7 and its association with IRF-3. Virology 280, 273-282 (2001).
94. Breiman, A. et al. Inhibition of RIG-1-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKε. J. Virol. 79, 3969-3978 (2005).